Wealth Enhancement Advisory Services
IRWD icon

Wealth Enhancement Advisory Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$913K Sell
219,445
-7,243
-3% -$27.9K ﹤0.01% 2139
2026
Q1 		$741K Buy
226,688
+71,165
+46% +$292K ﹤0.01% 2025
2025
Q4 		$665K Buy
155,523
+1,135
+0.7% +$2.95K ﹤0.01% 2262
2025
Q3 		$235K Buy
154,388
+28,928
+23% +$29.9K ﹤0.01% 2989
2025
Q2 		$96.1K Buy
125,460
+101,574
+425% +$79.7K ﹤0.01% 3144
2025
Q1 		$35.1K Buy
23,886
+10,651
+80% +$25.4K ﹤0.01% 2874
2024
Q4 		$58.6K Buy
+13,235
New +$53.7K ﹤0.01% 2854
2024
Q3 		– Sell
-13,608
Closed -$88.7K – 2863
2024
Q2 		$88.7K Buy
+13,608
New +$96.3K ﹤0.01% 2417

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
RFG
Range Financial Group Tigard, Oregon $366M AUM 76.17% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
DWM
Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return
RDFA
Ritter Daniher Financial Advisory Cincinnati, Ohio $657M AUM 20.27% 1-Year Est. Return

Wealth Enhancement Advisory Services's IRWD Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its Ironwood Pharmaceuticals (IRWD) stake by 3.2% in Q2 2026, selling an estimated $27.9K and leaving 219,445 shares worth $913K. The position accounts for ﹤0.01% of the portfolio, ranked #2139.

Wealth Enhancement Advisory Services first reported a position in IRWD in Q2 2024 and has held it in 8 quarters since. 11 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Wealth Enhancement Advisory Services held 219,445 shares of Ironwood Pharmaceuticals worth $913K as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 7,243 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $27.9K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2139 holding.
  • Wealth Enhancement Advisory Services first reported a position in Ironwood Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 11 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.